Danielle Hope Flandreau, ARNP

Danielle Flandreau practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Danielle Flandreau's NPI, 1508136367, was assigned on January 10, 2012. Danielle Flandreau holds Florida license ARNP9252460.

Danielle Flandreau's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Danielle Flandreau also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Danielle Flandreau's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Danielle Flandreau to 1 more breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Danielle Flandreau practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Danielle Flandreau's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Danielle Flandreau is licensed in Florida.

Dmand AI lists vitamin d deficiency among the conditions Danielle Flandreau treats.

CMS data shows 290 Medicare services from Danielle Flandreau across 3 procedure codes in 2024, for 113 Medicare patients. Medicare paid $19,391 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Danielle Flandreau in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have cancer, and 73% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Danielle Flandreau's median patient age at 61, with 98% women.

In 2024, Danielle Flandreau wrote 397 Medicare Part D claims for 124 patients. 86% of them were for generic drugs. CMS names the drug for 302 of them, across 6 drugs with 11 or more claims each, at $584,463 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Danielle Flandreau for performance year 2024, reported as part of a group. Danielle Flandreau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Danielle Flandreau as offering telehealth.